Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Topical Ruxolitinib may safely treat severe hair loss.

The flaky skin mouse mutation is a natural model for studying human psoriasis.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The new gel for psoriasis is effective, stable, and easy to apply.

Ferric carboxymaltose effectively improved iron deficiency anemia symptoms and increased hemoglobin and ferritin levels.

JAK inhibitors are effective treatments for alopecia areata.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

PCFCL may have unrecognized subtypes and needs more research.